TOP

ACLI & SOA ReFocus Conference

Proud to be a Diamond Sponsor. We look forward to this annual event each year.

Meeting Attendees

Spotlights Webinar Series

Our open-to-all sessions feature quarterly webinars on hot topics in the marketplace today. Presented by our Gen Re Life & Health experts and valued business partners.

SAVE THE DATE FOR OUR NEXT SESSION:
Tuesday, March 4, 2025 | 12:00 p.m. EST - 1:00 p.m. EST

Unlocking the Potential of GLP-1 Receptor Agonists: A New Horizon in Managing Complex Health Conditions?

Speaker: Dr. Jonah Fox, Chief Medical Director Global Claims

If you haven’t attended a seminar, please sign up today!

Behavioral Economics Academy Training

To apply BE to insurance, you first need to understand BE.

Gen Re clients have the ability to complete four online, professor-developed and -led training modules. Developed for professionals across all functions.

Every day, Gen Re's risk professionals deliver insights to help our clients continue to grow their business with confidence. Our wide range of products, tools and resources aim to promote our clients' ongoing growth and success.

Products

Information and collaboration are the basis for great innovation. We're here to support your initiaties - and find solutions to help you succeed.

Learn More

Underwriting and Actuarial Expertise

As your reinsurer, you can rely on our competent advice, comprehensive services, and effective tools and resources to guide your risk management decisions. We're here to help.

Learn More

Analytics

With our deep expertise in solving complex business problems, we generate actionable insights for our clients using a wide range of statistical and machine learning techniques.

Learn More

Claims Expertise

Gen Re Claims is committed to partnering with our clients to build and implement claims and risk management solutions, develop products, and deliver impactful learning forums.

Learn More

Some of the Topics We've Been Writing About

Can a Low-Price Strategy be Successful in Today’s Competitive Medicare Supplement Market?
Many insurers with low or stagnant sales are intrigued by the possibility of a new high-growth product in an attractive and rapidly growing senior market segment. This article explores whether a “low-price strategy” can ultimately be successful in today’s competitive Med Supp market.
Mark Willse
The Latest in Obstructive Sleep Apnea
Approximately one billion people across the globe are estimated to have Obstructive Sleep Apnea, making it the most common respiratory-related sleep disorder. Learn more about this medical condition including risk factors, how it’s diagnosed, complications, treatments and future therapies.
Dr. Jonah Fox
Investigating Foreign Deaths – Risks and Challenges
Foreign death claims pose unique risks and challenges for Life insurers, as they often involve complex legal and procedural issues across different jurisdictions. Insurers can mitigate the risks and protect themselves against potential fraud by ensuring they have robust controls in place.
Jason Weesner
Individual Life Accelerated Underwriting – Highlights of 2024 U.S. Survey
Sharing results from the Gen Re Individual Life Accelerated Underwriting Survey. Thirty-eight Individual Life insurance carriers participated in the study, though they may have been at varying stages of implementation with their Accelerated Underwriting workflow. Read about our survey highlights.
Ruth Potter
How Insurers Can Use Behavioral Economics Approaches to Make Improvements
At Gen Re, we often talk about ways to actively utilize BE approaches – in fact, one of our favorite catchphrases is “putting BE into action.” Implementing these important tools can help insurers in many ways.
Heidi Alpren, Joe Curtin, Ruth Potter
Key Takeaways From Our U.S. Claims Fraud Survey
Insurance fraud is a global threat for all lines of business, with significant financial repercussions. In the U.S. alone, insurance fraud is estimated to cost the industry approximately $308.6 billion per year. Here is a snapshot of findings from Gen Re’s 2024 U.S. Insurance Claims Fraud Survey.
Jason Weesner
Multiple Sclerosis – Something Old, Something New
As one of the most common neurologic conditions within the young adult population, MS is a major driver of disability and healthcare costs. Here’s an overview of the disease and update of medications and treatments, especially for Life & Health claims professionals.
Dr. Jonah Fox
Knife or Needle: Will the New Weight Loss Medication Replace Bariatric Surgery?
Obesity is a chronic, relapsing disease and requires long-term management. Glucagon-like peptide-1 (GLP-1) analogue semaglutide, approved as a weight loss medication, brought a promising alternative to surgical treatment. We describe the effects of GLP-1 analogues and compares them to bariatric surgery.
Dr. Sandra Mitic
Underwriting Disability Insurance – The Art and Science of Critical Thinking
Compelling evidence highlights the growing need for people to have income protection – and the importance of Disability insurance. Here we explore some aspects of its underwriting, including some of the complexities and nuances of assessing morbidity risk.
Dr. Loraine Oman-Ganes, Brenda Blaisdell
New Life & Health Technologies – A Double-edged Sword?
L&H leaders today are navigating through unprecedented change. New innovations in the market offer significant potential upside but also create negative impacts that must be managed.
Frank Chechel, Mike Fullerton
Harindra Chandrasena

Information and collaboration are the basis for great innovation. We leverage our actuarial, underwriting, claims, medical, and research expertise with market-specific knowledge to support your product initiatives.

Harindra Chandrasena
President & CEO, General Re Life Corporation

Learn more about us!

We work closely with our clients to understand their strategic and operational goals, offering a wide range of products, tools, and resources that aim to promote our clients’ ongoing growth and success.

Gen Re is a member of the Berkshire Hathaway family of companies, and our reinsurance operations hold superior financial strength ratings. With $17.7B in capital, we have significant capacity available.